诺沃北方公司的新药可显著降低2型糖尿病儿童血糖. Novo Nordisk's new oral pill shows significant blood sugar reduction for children with type 2 diabetes.

诺沃北方医药公司宣布,对儿童服用糖尿病丸的临床试验有前景,显示血糖显著降低. Novo Nordisk announced promising results from a clinical trial of an oral diabetes pill for children, showing significant blood sugar reduction. 每日服用一次的片剂为2型糖尿病年轻患者提供了新的非注射替代方案, 解决了对可访问儿科护理需求的不断增长. The once-daily tablet offers a new, non-injectable alternative for young patients with type 2 diabetes, addressing the growing need for accessible pediatric care.